RGACX
Price
$84.05
Change
-$1.88 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
STFFX
Price
$51.72
Change
-$0.96 (-1.82%)
Updated
Nov 13 closing price
Net Assets
1.01B
Interact to see
Advertisement

RGACX vs STFFX

Header iconRGACX vs STFFX Comparison
Open Charts RGACX vs STFFXBanner chart's image
American Funds Growth Fund of Amer R3
Price$84.05
Change-$1.88 (-2.19%)
VolumeN/A
Net Assets340.4B
Allspring Large Cap Growth R6
Price$51.72
Change-$0.96 (-1.82%)
VolumeN/A
Net Assets1.01B
RGACX vs STFFX Comparison Chart in %
View a ticker or compare two or three
VS
RGACX vs. STFFX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGACX is a Buy and STFFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 340B vs. STFFX (1.01B). RGACX pays higher dividends than STFFX: RGACX (0.07) vs STFFX (0.00). RGACX was incepted earlier than STFFX: RGACX (24 years) vs STFFX (13 years). RGACX (0.94) is less costly to investors than STFFX (0.76). STFFX is a more actively managed with annual turnover of: 44.00 vs. RGACX (25.00). STFFX has a lower initial minimum investment than RGACX: STFFX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 8.31 vs. STFFX (1.60). RGACX return over 5 years is better than : 37.90 vs. STFFX (-5.66).
RGACXSTFFXRGACX / STFFX
Total Expense Ratio0.940.60157%
Annual Report Gross Expense Ratio0.940.76124%
Fund Existence24 years13 years-
Gain YTD19.36417.879108%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets340B1.01B33,630%
Annual Yield % from dividends0.070.00-
Returns for 1 year8.311.60519%
Returns for 3 years63.3139.88159%
Returns for 5 years37.90-5.66-670%
Returns for 10 years98.369.241,064%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NPO219.095.00
+2.34%
Enpro
MBRX0.490.01
+1.82%
Moleculin Biotech
URI860.715.70
+0.67%
United Rentals
KBDC14.68-0.07
-0.47%
Kayne Anderson BDC Inc.
FENC7.78-0.14
-1.77%
Fennec Pharmaceuticals